These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38390736)

  • 1. A Population-Oriented Genetic Scoring System to Predict Phenotype: A Pathway to Personalized Medicine in Iraqis With β-Thalassemia.
    Al-Allawi N; Atroshi SD; Sadullah RK; Eissa AA; Kriegshäuser G; Al-Zebari S; Qadir S; Khalil D; Oberkanins C
    Hemoglobin; 2024 Mar; 48(2):94-100. PubMed ID: 38390736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Modifiers in β-Thalassemia Intermedia: A Study on 102 Iraqi Arab Patients.
    Al-Allawi NA; Puehringer H; Raheem RA; Oberkanins C
    Genet Test Mol Biomarkers; 2015 May; 19(5):242-7. PubMed ID: 25751242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Modifiers of Sickle Cell Disease: A Genotype-Phenotype Relationship Study in a Cohort of 82 Children on Mayotte Island.
    Muszlak M; Pissard S; Badens C; Chamouine A; Maillard O; Thuret I
    Hemoglobin; 2015; 39(3):156-61. PubMed ID: 25806420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphic variations influencing fetal hemoglobin levels: association study in beta-thalassemia carriers and in normal individuals of Portuguese origin.
    Pereira C; Relvas L; Bento C; Abade A; Ribeiro ML; Manco L
    Blood Cells Mol Dis; 2015 Apr; 54(4):315-20. PubMed ID: 25842369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Basis of β-Thalassemia Intermedia in Erbil Province of Iraqi Kurdistan.
    Shamoon RP; Al-Allawi NA; Cappellini MD; Di Pierro E; Brancaleoni V; Granata F
    Hemoglobin; 2015; 39(3):178-83. PubMed ID: 25902180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential genetic modifiers and their measurable impact in a community-recruited population analysis for non-severe hemoglobin E/β-thalassemia prenatal genetic counseling.
    Wong P; Chitsobhak T; Jittasathian S; Sirichantharawat C; Cherdchoo N; Prangcharoen W; Jongautchariyakul P; Jampachaisri K; Tapprom A; Deoisares R; Chumnumsiriwath P
    Blood Cells Mol Dis; 2023 Nov; 103():102765. PubMed ID: 37353362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of HBG2, BCL11A, and HBS1L-MYB polymorphisms to thalidomide response in Chinese β-thalassemia patients.
    Yang K; Wu Y; Ma Y; Xiao J; Zhou Y; Yin X
    Blood Cells Mol Dis; 2020 Sep; 84():102442. PubMed ID: 32387854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between four SNPs (rs7482144, rs4671393, rs28384513 and rs4895441) and fetal hemoglobin levels in Chinese Zhuang β-thalassemia intermedia patients.
    Lai Y; Zhou L; Yi S; Chen Y; Tang Y; Yi S; Yang Z; Wei H; Zheng C; He S
    Blood Cells Mol Dis; 2017 Mar; 63():52-57. PubMed ID: 28160732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-Locus Models to Address Hb F Variability in Portuguese β-Thalassemia Carriers.
    Manco L; Bento C; Relvas L; Cunha E; Pereira J; Moreira V; Alvarez M; Maia T; Ribeiro ML
    Hemoglobin; 2020 Mar; 44(2):113-117. PubMed ID: 32319326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulatory effect of single nucleotide polymorphism in Xmn1, BCL11A and HBS1L-MYB loci on foetal haemoglobin levels in β-thalassemia major and Intermedia patients.
    Bashir S; Mahmood S; Mohsin S; Tabassum I; Ghafoor M; Sajjad O
    J Pak Med Assoc; 2021 May; 71(5):1394-1398. PubMed ID: 34091621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Background of β-Thalassemia in Northeast Algeria with Assessment of the Thalassemia Severity Score and Description of a new β
    Abdaoui W; Benouareth DE; Djenouni A; Renoux C; Grifi F; Gouri A; Athamnia F; Benalioua M; Joly P
    Hemoglobin; 2019; 43(4-5):223-228. PubMed ID: 31603010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variants in genetic modifiers of β-thalassemia can help to predict the major or intermedia type of the disease.
    Badens C; Joly P; Agouti I; Thuret I; Gonnet K; Fattoum S; Francina A; Simeoni MC; Loundou A; Pissard S
    Haematologica; 2011 Nov; 96(11):1712-4. PubMed ID: 21791466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of HBG2, BCL11A, and HMIP polymorphisms with fetal hemoglobin and clinical phenotype in Iraqi Kurds with sickle cell disease.
    Al-Allawi N; Qadir SMA; Puehringer H; Chui DHK; Farrell JJ; Oberkanins C
    Int J Lab Hematol; 2019 Feb; 41(1):87-93. PubMed ID: 30216683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular characterization of Beta globin gene in thalassemia patients reveals rare and a novel mutations in Pakistani population.
    Yasmeen H; Toma S; Killeen N; Hasnain S; Foroni L
    Eur J Med Genet; 2016 Aug; 59(8):355-62. PubMed ID: 27263053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms underlying thalassemia intermedia in Iran.
    Neishabury M; Azarkeivan A; Oberkanins C; Esteghamat F; Amirizadeh N; Najmabadi H
    Genet Test; 2008 Dec; 12(4):549-56. PubMed ID: 18939939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of genetic modifiers of hemoglobinopathies leading towards precision medicine.
    Hariharan P; Gorivale M; Sawant P; Mehta P; Nadkarni A
    Sci Rep; 2021 Oct; 11(1):20906. PubMed ID: 34686692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The XmnI (G)gamma polymorphism influences hemoglobin F synthesis contrary to BCL11A and HBS1L-MYB SNPs in a cohort of 57 beta-thalassemia intermedia patients.
    Nguyen TK; Joly P; Bardel C; Moulsma M; Bonello-Palot N; Francina A
    Blood Cells Mol Dis; 2010 Aug; 45(2):124-7. PubMed ID: 20472475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amelioration of Sardinian beta0 thalassemia by genetic modifiers.
    Galanello R; Sanna S; Perseu L; Sollaino MC; Satta S; Lai ME; Barella S; Uda M; Usala G; Abecasis GR; Cao A
    Blood; 2009 Oct; 114(18):3935-7. PubMed ID: 19696200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Genetic Polymorphisms and Hb F Levels in Heterozygous β-Thalassemia 3.5 kb Deletions.
    Tepakhan W; Kanjanaopas S; Srewaradachpisal K
    Hemoglobin; 2020 Sep; 44(5):338-343. PubMed ID: 32878504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A rare thalassemia intermedia case caused by co-existence of Hb H disease (--(SEA)/-alpha(4.2)) and beta-thalassemia major (beta (CD17A)>T/beta (IVS2-654C)>T): implications for prenatal diagnosis].
    Li Q; Li LY; Mo QH
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jan; 28(1):16-9. PubMed ID: 18227017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.